These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 20117358

  • 1. A critical review of clinical arteriogenesis research.
    van Royen N, Piek JJ, Schaper W, Fulton WF.
    J Am Coll Cardiol; 2009 Dec 29; 55(1):17-25. PubMed ID: 20117358
    [Abstract] [Full Text] [Related]

  • 2. Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice.
    Schirmer SH, Fledderus JO, Bot PT, Moerland PD, Hoefer IE, Baan J, Henriques JP, van der Schaaf RJ, Vis MM, Horrevoets AJ, Piek JJ, van Royen N.
    Circ Res; 2008 May 23; 102(10):1286-94. PubMed ID: 18420941
    [Abstract] [Full Text] [Related]

  • 3. [Angiogenesis and arteriogenesis; the long road from concept to clinical application].
    Voskuil M, van Royen N, Hoefer I, Buschmann I, Schaper W, Piek JJ.
    Ned Tijdschr Geneeskd; 2001 Apr 07; 145(14):670-5. PubMed ID: 11530702
    [Abstract] [Full Text] [Related]

  • 4. [Mechanisms and potential of the therapeutic stimulation of arteriogenesis].
    Schirmer SH, van Royen N, Laufs U, Böhm M.
    Dtsch Med Wochenschr; 2009 Feb 07; 134(7):302-6. PubMed ID: 19197812
    [Abstract] [Full Text] [Related]

  • 5. Regulation of coronary blood flow during exercise.
    Duncker DJ, Bache RJ.
    Physiol Rev; 2008 Jul 07; 88(3):1009-86. PubMed ID: 18626066
    [Abstract] [Full Text] [Related]

  • 6. [Inducing collaterals in due time. Arteriogenesis as a preventive principle].
    Bondke A, Buschmann IR, Bode C, Buschmann EE.
    Hamostaseologie; 2007 Dec 07; 27(5):363-72. PubMed ID: 18060248
    [Abstract] [Full Text] [Related]

  • 7. Vascular remodeling and altered protein expression during growth of coronary collateral arteries.
    Wolf C, Cai WJ, Vosschulte R, Koltai S, Mousavipour D, Scholz D, Afsah-Hedjri A, Schaper W, Schaper J.
    J Mol Cell Cardiol; 1998 Nov 07; 30(11):2291-305. PubMed ID: 9925366
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of MCP-1 and leptin on collateral flow and arteriogenesis.
    Schirmer SH, Buschmann IR, Jost MM, Hoefer IE, Grundmann S, Andert JP, Ulusans S, Bode C, Piek JJ, van Royen N.
    Cardiovasc Res; 2004 Nov 01; 64(2):356-64. PubMed ID: 15485696
    [Abstract] [Full Text] [Related]

  • 9. Insights into mechanisms behind arteriogenesis: what does the future hold?
    van Oostrom MC, van Oostrom O, Quax PH, Verhaar MC, Hoefer IE.
    J Leukoc Biol; 2008 Dec 01; 84(6):1379-91. PubMed ID: 18678607
    [Abstract] [Full Text] [Related]

  • 10. Influence of inflammatory cytokines on arteriogenesis.
    Buschmann I, Heil M, Jost M, Schaper W.
    Microcirculation; 2003 Jun 01; 10(3-4):371-9. PubMed ID: 12851653
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cardiovascular risk factors and collateral artery formation.
    de Groot D, Pasterkamp G, Hoefer IE.
    Eur J Clin Invest; 2009 Dec 01; 39(12):1036-47. PubMed ID: 19845740
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Stretch-induced activation of the transcription factor activator protein-1 controls monocyte chemoattractant protein-1 expression during arteriogenesis.
    Demicheva E, Hecker M, Korff T.
    Circ Res; 2008 Aug 29; 103(5):477-84. PubMed ID: 18669921
    [Abstract] [Full Text] [Related]

  • 18. [Arteriogenesis: a new strategy of therapeutic intervention in chronic arterial disorders. Cellular mechanism and experimental models].
    Erdo F, Buschmann IR.
    Orv Hetil; 2007 Apr 08; 148(14):633-42. PubMed ID: 17403636
    [Abstract] [Full Text] [Related]

  • 19. Galectin-2 expression is dependent on the rs7291467 polymorphism and acts as an inhibitor of arteriogenesis.
    van der Laan AM, Schirmer SH, de Vries MR, Koning JJ, Volger OL, Fledderus JO, Bastiaansen AJ, Hollander MR, Baggen JM, Koch KT, Baan J, Henriques JP, van der Schaaf RJ, Vis MM, Mebius RE, van der Pouw Kraan TC, Quax PH, Piek JJ, Horrevoets AJ, van Royen N.
    Eur Heart J; 2012 May 08; 33(9):1076-84. PubMed ID: 21831908
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.